Olema Pharmaceuticals, Inc.·4

Nov 19, 6:57 PM ET

Moriarty John B 4

4 · Olema Pharmaceuticals, Inc. · Filed Nov 19, 2020

Insider Transaction Report

Form 4
Period: 2020-09-19
Moriarty John B
EVP, Ch. Legal Officer & Sec.
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-11-18+161,406161,406 total
    Exercise: $19.00Exp: 2030-11-17Common Stock (161,406 underlying)
  • Award

    Stock Option (Right to Buy)

    2020-09-19+252,060252,060 total
    Exercise: $4.82Exp: 2030-09-18Common Stock (252,060 underlying)
Footnotes (2)
  • [F1]25% of the shares subject to the option vest on September 8, 2021 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. The stock option is early exercisable.
  • [F2]25% of the shares subject to the option vest on November 18, 2021 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION